Johansen P W, Sand O, Iversen J G, Haug E, Gautvik K M
Acta Endocrinol (Copenh). 1986 Feb;111(2):185-92. doi: 10.1530/acta.0.1110185.
The effects of the dopamine (DA) agonist bromocriptine on prolactin (Prl) release, electrical membrane properties and transmembrane Ca2+ fluxes have been studied in a clonal strain of rat pituitary adenoma cells (GH3). These cells generate Ca2+ dependent action potentials, and produce and secrete spontaneously both Prl and growth hormone. Prl release stimulated by thyroliberin (TRH) and elevated extracellular K+ concentration was completely blocked by bromocriptine, whereas the basal release was only moderately affected. The TRH and K+ evoked Prl release were half maximally inhibited by bromocriptine at 5-10 and 10-50 microM, respectively. The normal biphasic membrane response to TRH and the depolarizing effect of elevated K+ concentration were not altered by bromocriptine, whereas the Ca2+- spikes in Na+-free solution were suppressed by the drug. We therefore suggest that bromocriptine blocks the voltage sensitive Ca2+-channels of GH3 cell. In agreement with this notion, bromocriptine also suppressed the basal and TRH induced 45Ca2+ efflux from preloaded cells. We conclude that the inhibitory effect of bromocriptine on the voltage dependent Ca2+- channels is an important mechanism responsible for suppression of Prl release.
在大鼠垂体腺瘤细胞(GH3)的克隆株中,研究了多巴胺(DA)激动剂溴隐亭对催乳素(Prl)释放、电膜特性和跨膜Ca2+通量的影响。这些细胞产生依赖Ca2+的动作电位,并自发产生和分泌Prl及生长激素。促甲状腺素释放激素(TRH)和细胞外K+浓度升高所刺激的Prl释放被溴隐亭完全阻断,而基础释放仅受到中度影响。TRH和K+诱发的Prl释放分别在5 - 10微摩尔和10 - 50微摩尔的溴隐亭作用下被半数最大抑制。溴隐亭未改变对TRH正常的双相膜反应以及K+浓度升高的去极化作用,而在无钠溶液中的Ca2+尖峰被该药物抑制。因此我们认为,溴隐亭阻断了GH3细胞的电压敏感性Ca2+通道。与此观点一致,溴隐亭也抑制了预加载细胞的基础及TRH诱导的45Ca2+外流。我们得出结论,溴隐亭对电压依赖性Ca2+通道的抑制作用是其抑制Prl释放的重要机制。